Shire to sell 100-employee Milford site as part of manufacturing slim-down

Rare disease drugmaker Shire, one of the state ’s biggest life science employers, is in active negotiations to sell one of its manufacturing sites in Milford, according to a top executive. Shire (Nasdaq: SHPG) announced as part of its third quarter earnings on Friday that it plans to implement a cost-cutting program targeting its manufacturin g operations. In an interview, the company’s head of technical operations, Matt Walker, told the Business Journal that Shire is divesting five of its 17…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news